Acute systemic administration of combined drug treatments with amylin, GLP-1, sCT and liraglutide We first aimed to investigate the behavioral mechanism by which combined activation of amylin receptors and GLP-1R suppress food intake in lean rodents using various pharmacological combinations of native amylin with native GLP-1(736), as well as combined administration of the amylin receptor/calcitonin receptor agonist, sCT, together with the GLP-1R agonist, liraglutide
Comput Biol Chem 100:107736
178 GuareschiS.CovaE.CeredaC.CeroniM.DonettiE.BoscoD
Wang, K., Li, Q., Ren, Z., Li, C., Chu, Y., Wang, Z., Zhang, M., Wu, H., Zhang, Q.: 2D metalorganic frameworks (MOFs) for highperformance batcap hybrid devices small
Chemical leukoderma often begins where a product repeatedly touches the skin